Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin

NCT00119314 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped slow accrual

Conditions

Carcinoma of Unknown Primary

Interventions

DRUG: capecitabine
DRUG: docetaxel
DRUG: gemcitabine hydrochloride
PROCEDURE: positron emission tomography

Sponsor

University of Medicine and Dentistry of New Jersey

Collaborators

[object Object]